Masachussetts General Hospital Cancer Center — Boston, Massachusetts

Masachussetts General Hospital Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Masachussetts General Hospital Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Prostatic Neoplasms, Prostate Cancer.

Sponsors: Cougar Biotechnology, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Masachussetts General Hospital Cancer Center?

Masachussetts General Hospital Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Masachussetts General Hospital Cancer Center conducted?

Masachussetts General Hospital Cancer Center has 1 clinical trials on record. Their work covers Prostatic Neoplasms, Prostate Cancer.

Is Masachussetts General Hospital Cancer Center accredited by Crixeo Health?

Masachussetts General Hospital Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Masachussetts General Hospital Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.